AdvanSix Q3 Sales Rise 15%, but Production Pressure Widens Loss

AdvanSix Inc. (NYSE: ASIX) reported a wider third-quarter loss as lower production and rising raw-material costs outweighed a 15% increase in sales, despite pricing actions that recovered most of the input-cost inflation. The company generated stronger quarterly cash flow and expects working-capital benefits to continue in the fourth quarter.

Sales rose to $431 million from $374 million a year earlier. Pricing contributed 17 percentage points of growth, including 10 points from raw-material pass-through mechanisms and 7 points from market-based pricing, while volume reduced growth by 2 points.

Higher pricing across all product lines nearly offset increased input costs, but lower production at the Hopewell and Frankford facilities weakened fixed-cost absorption. Adjusted EBITDA fell to $15 million from $25 million, and adjusted EBITDA margin narrowed to 3.4% from 6.6%. Adjusted loss per share was $0.24, compared with adjusted earnings of $0.08 per share in the prior-year quarter.

On a GAAP basis, AdvanSix recorded a net loss of $7.6 million, or $0.28 per share, compared with a net loss of $2.6 million, or $0.10 per share, a year earlier. The third-quarter effective tax rate was 32.1%, up from 25.6% in the prior-year period. The company said the year-to-date 2025 tax rate had benefited from 45Q carbon-capture tax credits.

Production Pressure Offsets Pricing

AdvanSix said higher prices added $61 million to adjusted EBITDA compared with the prior year, while raw-material inflation reduced it by $65 million. That cost pressure included $32 million from sulfur, $30 million from benzene and $5 million from propylene, partly offset by a $2 million benefit from natural gas. Volume and reduced fixed-cost absorption lowered adjusted EBITDA by another $8 million. Lower selling, general and administrative expense provided a $3 million benefit as the company continued its cost-saving initiatives.

Plant Nutrients sales increased 8% year over year to $149 million. The company said its North American ammonium sulfate fill program resulted in a seasonal sequential decline in domestic pricing, while volumes improved after reduced in-season purchases during the second quarter.

Nylon sales climbed 33% to $105 million, with higher resin volumes supported by improved operational performance. Chemical Intermediates sales rose 24% to $104 million, while caprolactam sales were approximately flat at $73 million. AdvanSix said it maintained margin expansion across Nylon Solutions and Chemical Intermediates and expects continued strong domestic granular ammonium sulfate volumes for the 2026-2027 fertilizer year.

Cash Flow Improves as Capital Spending Declines

Cash provided by operations reached $48 million, up $21 million from a year earlier, primarily because of favorable working-capital changes. Capital expenditures declined by $8 million to $18 million, contributing to free cash flow of $30 million versus approximately zero in the third quarter of 2025.

For the first nine months of 2026, operating cash flow was $43 million and capital spending totaled $75 million, resulting in negative free cash flow of $32 million. AdvanSix expects working-capital tailwinds to continue into the fourth quarter, supported by advance payments tied to ammonium sulfate pre-buy activity amid elevated fertilizer pricing.

The company expects approximately $90 million of capital expenditures for full-year 2026, reflecting a reduced spending run rate and risk-based prioritization of base investments. It is also commissioning the synthetic ammonium sulfate project within its SUSTAIN growth program. The planned fourth-quarter ammonia turnaround is expected to have an approximately $7 million impact on pretax income, bringing the estimated full-year turnaround impact to about $17 million.

Growth Investments and 2027 Considerations

AdvanSix expects to make a final investment decision on its diesel exhaust fluid growth project in the second quarter of 2027. Project CENTURY, a proposed modernization and expansion of ammonia manufacturing at the Hopewell, Virginia, facility, was selected to advance through the U.S. Department of Agriculture’s FIELDS grant process.

The project contemplates approximately $98 million of investment from 2027 through 2031 and about $47 million of proposed USDA funding. It is designed to add roughly 84,000 tons of annual ammonia capacity, improve reliability and logistics, and modernize operating controls. AdvanSix expects the project’s internal rate of return to exceed its 20% hurdle rate, although grant funding remains subject to USDA administrative and risk reviews.

Looking into the first half of 2027, management is monitoring lower global phenol operating rates, the building and construction cycle, interest rates, automotive and consumer-durables demand, and global caprolactam and nylon capacity rationalization. The company also cited more favorable farmer economics and crop-price trends, tighter ammonium sulfate supply, improving demand and expected benefits from normalizing sulfur costs.

AdvanSix remains exposed to volatility in benzene, sulfur, propylene and energy costs, as well as production interruptions and turnaround execution. The company also identified tariffs, supply-chain disruptions, geopolitical conditions, changing end-market demand, environmental requirements, indebtedness and access to capital among the uncertainties that could affect results.